| Literature DB >> 27485279 |
Murthy Yerramilli1, Giosi Farace2, John Quinn2, Maha Yerramilli2.
Abstract
Chronic kidney disease (CKD) and acute kidney injury (AKI) are interconnected and the presence of one is a risk for the other. CKD is an important predictor of AKI after exposure to nephrotoxic drugs or major surgery, whereas persistent or repetitive injury could result in the progression of CKD. This brings new perspectives to the diagnosis and monitoring of kidney diseases highlighting the need for a panel of kidney-specific biomarkers that reflect functional as well as structural damage and recovery, predict potential risk and provide prognosis. This article discusses the kidney-specific biomarkers, symmetric dimethylarginine (SDMA), clusterin, cystatin B, and inosine.Entities:
Keywords: AKI; Biomarkers; CKD; Diagnostics; Kidney; Renal; SDMA
Mesh:
Substances:
Year: 2016 PMID: 27485279 DOI: 10.1016/j.cvsm.2016.06.011
Source DB: PubMed Journal: Vet Clin North Am Small Anim Pract ISSN: 0195-5616 Impact factor: 2.093